Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Denies Breaking Trade Truce as U.S.-China Tensions Escalate

by Team Lumida
June 2, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Manufacturing Powerhouse Faces Domestic Struggles: What It Means for Global Investors

"MY ROAD : FLAG OF CHINA" by Lαin is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China rejected President Trump’s accusations of violating a trade truce, claiming it upheld the Geneva consensus while accusing the U.S. of undermining the agreement with restrictive measures.
  • Tensions have flared over issues such as U.S. export controls on AI chips, visa restrictions for Chinese students, and China’s rare-earth mineral exports.
  • Trump reiterated his accusations, stating he plans to discuss the matter with Chinese President Xi Jinping.
  • The breakdown in progress toward a deal has rattled markets, with Hong Kong’s Hang Seng Index falling 2.2% and the Hang Seng Tech Index dropping 2.4%.

What Happened?

China’s Commerce Ministry pushed back against President Trump’s claims that Beijing violated a trade truce reached in mid-May during talks in Geneva. The agreement had temporarily lowered tariffs, offering a brief reprieve to global markets.

In a statement, China accused the U.S. of undermining the consensus by introducing “discriminatory and restrictive measures,” including export controls on AI chips and visa revocations for Chinese students. Trump, however, accused China of violating “a big part of the agreement” and expressed his intention to discuss the issue with Chinese President Xi Jinping.

The renewed tensions have dampened optimism for a lasting trade deal, with markets reacting negatively. Chinese stocks in Hong Kong fell sharply, led by declines in the Hang Seng Index and Hang Seng Tech Index.


Why It Matters?

The re-escalation of U.S.-China trade tensions highlights the fragility of the temporary truce and the challenges in reaching a lasting agreement. Key issues, such as technology export controls and rare-earth mineral exports, remain contentious, further complicating negotiations.

The market reaction underscores the economic stakes of the ongoing trade dispute. Declines in Chinese equities reflect investor concerns about the potential for prolonged uncertainty and its impact on global trade and economic growth.

Trump’s accusations and China’s counterclaims also signal a deepening mistrust between the two superpowers, raising questions about the feasibility of resolving broader geopolitical and economic tensions.


What’s Next?

President Trump’s planned discussion with Chinese President Xi Jinping will be closely watched for signs of progress or further escalation. Meanwhile, markets will monitor developments in U.S.-China relations, including potential retaliatory measures from Beijing.

Investors will also keep an eye on the impact of U.S. export controls and visa restrictions, as well as China’s response to Trump’s threat to double tariffs on steel and aluminum imports. The outcome of these disputes will shape the trajectory of global markets and trade dynamics in the coming months.

Source
Tags: China
Previous Post

Corporate Pension Funds Shift Strategies Amid Full Funding, Impacting Bonds and Private Equity

Next Post

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Recommended For You

Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

by Team Lumida
3 hours ago
Dollar Steadies, Euro and Sterling Vulnerable as Markets Await Fed Decision; Bitcoin Trades at 4-Week Lows

Currencies position ahead of Fed rate hike; dollar strength pressures EUR, GBP, AUD; Bitcoin at $75,886 after Clarity Act fails; forward guidance key to currency moves.

Read more

Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

by Team Lumida
1 day ago
Bank of England Eyes End to Long-Dated Bond Sales as 30-Year Gilts Approach 6%, Shifting Quantitative Tightening Strategy

The BOE may cease selling 20 and 30-year bonds despite heavy losses, marking a reversal of recent messaging as energy prices and inflation expectations pressurize sterling debt.

Read more

10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

by Team Lumida
1 day ago
10-Year Treasury Yield Hits 5.025%, Highest Since 2007, as Markets Price 92% Odds of Fed Hike

The 10-year yield surged to 5.025% as inflation remains above the Fed's target, with traders betting heavily on a 25-basis-point rate increase this week.

Read more

BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

by Team Lumida
2 days ago
BIS Warns Leveraged Hedge Funds Pose Growing Systemic Risk After Situational Awareness Near-Collapse

The Bank for International Settlements flagged the July near-collapse of Leopold Aschenbrenner's AI-focused hedge fund as evidence that leveraged funds have become a core financial stability risk.

Read more

Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

by Team Lumida
2 days ago
Study Finds Trump’s Drug-Pricing Push Incentivizes Higher Prices and Reduced Access Outside the US

A Lancet study found that for roughly three in four drugs studied, matching US Medicare prices to cheaper reference countries would cost companies more than they earn in...

Read more

Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

by Team Lumida
2 days ago
Chevron Says It Needs EU Methane Rule Clarity Before Committing to LNG Import Infrastructure

Chevron is weighing investment in European LNG regasification capacity but wants clearer methane regulations before making long-term commitments, its global gas president said.

Read more

Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

by Team Lumida
2 days ago
Russia Outpaces US and NATO on Cheap Weapons Production, Fueled by Chinese Components

Russia has fielded new Geran drones and Banderol cruise missiles at roughly $100,000 each, built on Chinese electronics, faster than Ukraine or Western militaries can match.

Read more

10-Year Treasury Yield Holds Near 4.97% as Markets Price 86.7% Odds of a Fed Hike This Week

by Team Lumida
2 days ago
Lumida Wealth Whale Watch Q2’24 : Macro Funds

Treasury yields were little changed Monday as investors weighed whether a move above 5% on the 10-year would come from healthy growth or from stress in the bond...

Read more

BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

by Team Lumida
5 days ago
BMO and Sun Life Commit C$75 Billion to Canada’s Infrastructure Build, Days Before Carney’s Toronto Investor Summit

BMO pledged up to C$70 billion over a decade and Sun Life C$5 billion for Canadian infrastructure, ahead of Mark Carney's investor summit in Toronto.

Read more

10-Year Treasury Yield Hits 4.94%, Closest to 5% Since 2023 as Traders Price 70% Odds of a September Fed Hike

by Team Lumida
5 days ago
Saudi Arabia Leads $321B EM Bond Spree: What Investors Need to Know

The 10-year Treasury yield climbed to 4.94% ahead of August CPI, with traders pricing roughly 70% odds of a Fed rate hike on Sept. 16.

Read more
Next Post
Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

AI Investment Boom: How Tech Giants Are Leading the Charge

AI Models Show Alarming Ability to Evade Human Control, Highlighting Urgent Need for Alignment Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

white and black car

FedEx Technology Chief Steps Down After Probe Into Dataworks Unit’s Performance Claims

July 18, 2025
people holding us a flag during daytime

Nearly 90% of Americans Have It and Don’t Know It: First Guidelines Issued for CKM Syndrome

June 10, 2026
Crypto Exchange Kraken Explores Nuclear Power

Kraken Unit Inks $100 Million Private Loan With New Gulf Firm

June 17, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018